Gianvi® Pancreatitis Lawsuit

As with all fourth generation oral contraceptives, Gianvi utilizes drospirenone to assist in the prevention of unwanted pregnancies. However, Gianvi introduces a second active ingredient, ethinyl estradiol, to further enhance the effects. Unfortunately, recent studies suggest that the inclusion of drospirenone may result in catastrophic complications. Our law firm is currently investigating the potential…

Read More

Hospitals Scrutinized for NovoSeven Off-label Use

Hospitals across the United States have become the subject of intense scrutiny after using the hemophilia drug NovoSeven almost exclusively for off-label purposes. According to a study published by The Annals of Internal Medicine, hospitals all over the country have been using NovoSeven to prevent bleeding over the course of surgery. As a result,…

Read More

Mitral Valve Disease Lawyer & Lawsuit

The rare congenital birth defect referred to as mitral valve disease is characterized by a malfunctioning valve between the left heart chambers. The defective valve either allows blood to leak back through where it originally came from or the valve itself is too narrow to allow sufficient blood flow. Regardless of the defect, mitral…

Read More

Gianvi® Deep Vein Thrombosis Lawsuit

As the generic version of Yaz, Gianvi (drospirenone and ethinyl estradiol) is intended to assist in the prevention of pregnancy in women who choose the method of oral birth control. When used as directed, Gianvi has proven to be 99% effective. However, the introduction of fourth generation contraceptives that contain drospirenone may coincide with…

Read More

SimplyThick Linked to Life-Threatening Conditions in Infants

As a food additive, SimplyThick is indicated to assist in the process of swallowing in those who exhibit a genetic predisposition for dysphagia and infants who are unable to do so on their own. Of significant concern, however, are reports by the U.S. Food and Drug Administration (FDA) cautioning the use of SimplyThick by…

Read More

Gianvi® Pulmonary Embolism Lawsuit

As a fourth generation contraceptive, Gianvi combines drospirenone with ethinyl estradiol to assist in the prevention of unwanted pregnancy. However, recent evidence lends weight to the long-suspected link between drospirenone-containing products and severe, life-threatening complications. Women who use Gianvi for a prolonged period of time may significantly increase their risk of developing a pulmonary…

Read More

FDA Inquiry Leads to Hip Implant Phaseout

In continuing with recent trends, bad news continues to surface on behalf of the recent transgressions committed by the Johnson & Johnson (J&J) subsidiary DePuy. According to administrative and corporate records, 2009 witnessed J&J executives initiate a phase out plan that would relinquish their remaining inventories of Articular Surface Replacement (ASR) Hip Systems. However,…

Read More

Duetact® Lawyer & Lawsuit

Intended to regulate blood sugar levels in patients who do not use daily insulin injections, Duetact (generic: glimepiride and pioglitazone) assists in the treatment of type 2 diabetes. However, recent evidence lends weight to the long-suspected link between pioglitazone-containing medications and severe, life-threatening complications. Patients who implement a strict Duetact regimen for a prolonged…

Read More